Related Experiment Video
Updated: Jan 19, 2026

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes
Published on: March 19, 2019
An overview of leishmanization experience: A successful control measure and a tool to evaluate candidate vaccines
Mehdi Mohebali1, Abolhassan Nadim2, Ali Khamesipour3
1Department of Medical Parasitology & Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Research Center for Endemic Parasites of Iran, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:
Leishmanization (LZ) is an intradermal inoculation of live Leishmania to induce an artificial cutaneous leishmaniasis (CL) lesion in a covered part of the body to protect against further natural CL lesion development. Leishmanization has been used from ancient times and when NNN medium was developed continued with using Leishmania from culture media. The objective of this study was to review LZ published experiences. This article is a review of LZ experiences and historical studies initiated since 1910 when Leishmania promastigotes were harvested from culture media and used for LZ. This review includes LZ experiences in Israel, some countries of Former Soviet Union and Iran. The results of LZ in Israel, some countries of Former Soviet Union and Iran showed that despite limitations, using this method significantly reduced the incidence rate of CL among leishmanized individuals in endemic areas. In conclusion, leishmanization using Leishmania major produced under GMP guideline is a valuable tool to protect against CL, there are limitations which need further study.
Related Concept Videos
10:16Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes
Controls in Experiments
09:04In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
08:52Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Vaccinations
04:51Measuring Immunoglobulin G Levels Against a Test Vaccine in a Mouse Serum

